HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adult brain low-grade astrocytomas: survival after surgery and radiotherapy.

Abstract
In order to identify prognostic factors of survival, twelve elements of disease and treatment have been evaluated for a population of 49 patients with diffuse low-grade astrocytoma treated with surgical resection and radiotherapy. The survival values were inversely correlated with age and major residual portion. On the other hand, KPS, lobar site, grade II Daumas-Duport lesions, protoplasmatic variant, early epilepsy, hyperfractionated radiotherapy and extent of exeresis were prognostic factors correlated with survival. Tumor extent and radiation total dose were not correlated in a meaningful way. Only KPS was statistically significant when compared to all the prognostic factors. We believe that patient selection according to age, lesion site and histological features are not sufficient to generate a homogeneous tumoral population. The most appropriate therapy for treating low-grade astrocytomas is still an open subject. However, recent studies have shown that the prognostic value of a group of factors is useful to plan controlled studies that compare differentiated treatment protocols.
AuthorsV M Arienti, A Botturi, A Boiardi, G Broggi, M Collice, L Fariselli, D Zanni, M Botturi
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) Vol. 22 Issue 3 Pg. 233-8 (Jun 2001) ISSN: 1590-1874 [Print] Italy
PMID11731876 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Astrocytoma (mortality, radiotherapy, surgery)
  • Brain Neoplasms (mortality, radiotherapy, surgery)
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Radiation Dosage
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: